COMPAGNIE LOMBARD ODIER SCMA – Vertex Pharmaceuticals Incorporated Transaction History
COMPAGNIE LOMBARD ODIER SCMA portfolio value:
$376,000
portfolio value
COMPAGNIE LOMBARD ODIER SCMA quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -20.25% | -330 shares | -84K | $289.54 | 1.3K |
| Q2 2022 | share | 0.00% | 0 shares | 35K | $281.79 | 1.63K | |
| Q1 2022 | share | 0.00% | 0 shares | 67K | $260.97 | 1.63K | |
| Q4 2021 | share | Increase | +328.95% | 1.25K shares | 289K | $222.45 | 1.63K |
| Q3 2021 | share | 0.00% | 0 shares | -7K | $181.39 | 380 | |
| Q2 2021 | share | Increase | +52.00% | 130 shares | 22K | $201.63 | 380 |
| Q1 2021 | share | Increase | 0.00% | 250 shares | 54K | $214.89 | 250 |
| Q3 2020 | share | Decrease | -100.00% | -325 shares | -94K | $272.12 | 0 |
| Q2 2020 | share | Increase | +30.00% | 75 shares | 35K | $290.31 | 325 |
| Q1 2020 | share | Increase | 0.00% | 250 shares | 59K | $237.95 | 250 |
| Q1 2019 | share | Decrease | -100.00% | -300 shares | -50K | $183.95 | 0 |
| Q4 2018 | share | Decrease | -40.00% | -200 shares | -46K | $165.71 | 300 |
| Q3 2018 | share | 0.00% | 0 shares | 11K | $192.74 | 500 | |
| Q2 2018 | share | Increase | 0.00% | 500 shares | 85K | $169.96 | 500 |